Biotech entity

Senate Health and Welfare Committee

organization

All 1 tracked stories fall under one category: pharma. Senate Health and Welfare Committee is most often covered alongside FDA, which appears in 1 of these 1 story. Senate Health and Welfare Committee appears in 1 tracked Biotech story from March 21, 2026.

Last mentioned: Mar 21, 2026

Entity pulse

Recent coverage · Senate Health and Welfare Committee

1 story
6 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Senate Health and Welfare Committee

All 1 tracked stories fall under one category: pharma. Senate Health and Welfare Committee is most often covered alongside FDA, which appears in 1 of these 1 story. Senate Health and Welfare Committee appears in 1 tracked Biotech story from March 21, 2026. The tracked stories average 2 original sources each.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 12 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Senate Health and Welfare Committee. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Implementation Phase

    Earliest possible date for new testing and labeling requirements to take effect.

  2. Legislative Vote

    Anticipated date for the full Senate vote on the regulatory package.

  3. Public Testimony

    Scheduled window for health experts and industry advocates to testify.

  4. Bill Introduction

    Senate committee formally introduces the kratom regulation bill.

Stories mentioning Senate Health and Welfare Committee 1

Pharma Neutral

Senate Committee Shifts Strategy Toward Kratom Regulation Over Total Ban

An Idaho Senate committee has introduced a bill to regulate the sale and distribution of kratom, marking a significant departure from previous efforts to implement a total ban. The proposed legislation focuses on consumer safety through mandatory testing, age restrictions, and standardized labeling for the botanical substance.

2 sources

Senate Health and Welfare Committee is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.